Global X Management Company’s BeOne Medicines Ltd ONC Stock Holding History

Global X Management Company’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$109K	Sell	706 -107	-13%	-$19.1K	﹤0.01%	999
2018 Q1	$137K	Buy	813 +202	+33%	+$27.4K	﹤0.01%	946
2017 Q4	$60K	Buy	611 +148	+32%	+$13.5K	﹤0.01%	895
2017 Q3	$48K	Buy	463 +67	+17%	+$4.99K	﹤0.01%	935
2017 Q2	$18K	Buy	+396	New	+$15.6K	﹤0.01%	1170

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Global X Management Company's ONC Position: Q2 2018 in Review

Global X Management Company reduced its BeOne Medicines Ltd (ONC) stake by 13% in Q2 2018, selling an estimated $19.1K and leaving 706 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Global X Management Company first reported a position in ONC in Q2 2017 and has held it in 5 quarters since. The position peaked at $137K in Q1 2018. 128 funds tracked by Wall St. Rank hold ONC as of Q2 2018.

Global X Management Company held 706 shares of BeOne Medicines Ltd worth $109K as of Q2 2018.
Global X Management Company sold 107 BeOne Medicines Ltd shares in Q2 2018, an estimated $19.1K.
BeOne Medicines Ltd made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #999 holding.
Global X Management Company first reported a position in BeOne Medicines Ltd in Q2 2017 and has held it in 5 quarters since.
Global X Management Company's BeOne Medicines Ltd position peaked at $137K in Q1 2018.
128 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.